X4 Pharmaceuticals, Inc Quarterly Other Assets, Noncurrent in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
X4 Pharmaceuticals, Inc quarterly Other Assets, Noncurrent history and growth rate from Q4 2017 to Q3 2024.
  • X4 Pharmaceuticals, Inc Other Assets, Noncurrent for the quarter ending September 30, 2024 was $2.36M, a 90% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.36M +$1.12M +90% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $1.79M +$710K +65.8% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.49M +$490K +48.9% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $1.44M +$211K +17.2% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $1.24M -$293K -19.1% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.08M -$719K -40% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1M -$644K -39.1% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $1.23M -$498K -28.9% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $1.54M -$468K -23.3% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $1.8M -$206K -10.3% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $1.65M -$745K -31.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.72M -$1.54M -47.1% Dec 31, 2021 10-K 2023-03-21
Q3 2021 $2.01M -$543K -21.3% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $2M -$1.47M -42.3% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $2.39M +$11K +0.46% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $3.26M +$1.31M +67.2% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $2.55M Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $3.47M +$3.37M +3176% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $2.38M +$2.28M +2379% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $1.95M +$1.59M +435% Dec 31, 2019 10-K 2021-03-19
Q2 2019 $106K Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $96K Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $364K -$584K -61.6% Dec 31, 2018 10-K 2020-03-12
Q3 2018 $101K Sep 30, 2018 10-Q 2018-11-09
Q4 2017 $948K Dec 31, 2017 10-K 2019-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.